Table 3 ICG-R15 and tomoelastography indexes between patients with different liver fibrosis grades
Liver fibrosis frade | F1–2 (n = 21) | F3–4 (n = 48) | p value |
|---|---|---|---|
ICG-R15, % (range) | 4.9 (1.8–14.0) | 9.2 (1.3–48.0) | *0.005 |
Liver | |||
 c (m/s) | 1.64 ± 0.14 | 2.13 ± 0.42 | * < 0.001 |
 φ (rad) | 0.70 ± 0.07 | 0.82 ± 0.12 | * < 0.001 |
Age, years (range) | 58 ± 12 (38–81) | 58 ± 9 (38–74) | 0.937 |
Sex (male/female) | 18:2 | 31:10 | 0.325 |
BMI (kg/m2) | 24.1 ± 3.3 | 23.5 ± 2.9 | 0.501 |
Laboratory results | |||
 ALB (g/L) | 39.29 ± 4.57 | 38.73 ± 6.98 | 0.739 |
 PAB (mg/L) | 208.05 ± 60.8 | 170.00 ± 61.85 | *0.021 |
 TB (μmol/L) | 16.39 ± 4.50 | 22.13 ± 13.56 | 0.066 |
 AST (U/L) | 26.0 (23.5, 42.5) | 35.5 (24.5, 56.8) | 0.196 |
 ALT (U/L) | 30.0 (19.5, 60.0) | 25.5 (20.0, 41.3) | 0.393 |
 PLT (×109/L) | 172.25 ± 53.32 | 111.39 ± 49.03 | * < 0.001 |
 PT (s) | 12.24 ± 1.09 | 12.94 ± 1.36 | *0.042 |
 INR | 1.04 ± 0.09 | 1.10 ± 0.12 | *0.039 |